Institute of Biochemical Sciences and Technology, Chaoyang University of Technology, Wufeng, Taiwan, ROC.
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6508-12. doi: 10.1016/j.bmcl.2010.09.056. Epub 2010 Sep 17.
The present Letter identified 2'-hydroxy-2,3,4',6'-tetramethoxychalcone (HTMC) as a potent in vitro cytotoxic agent with selective activity against cell lines derived from human lung cancer. In A549 lung adenocarcinoma cells, HTMC caused G1 phase cell-cycle arrest. HTMC treatment also led to an inhibition of cell-cycle regulatory proteins phosphorylation of cdc2 (Tyr(15) and Tyr(161)) and Rb (Ser(795) and Ser(807/811)), which was accompanied by the accumulation of tumor suppressor genes p53 and p21. In addition, in vivo data demonstrated that HTMC act as a tumor growth suppressing agent.
这封信件指出 2'-羟基-2,3,4',6'-四甲氧基查耳酮(HTMC)是一种有效的体外细胞毒性剂,对源自人类肺癌的细胞系具有选择性活性。在 A549 肺腺癌细胞中,HTMC 导致 G1 期细胞周期停滞。HTMC 处理还导致细胞周期调节蛋白 cdc2(Tyr(15) 和 Tyr(161)) 和 Rb (Ser(795) 和 Ser(807/811))的磷酸化抑制,这伴随着肿瘤抑制基因 p53 和 p21 的积累。此外,体内数据表明 HTMC 作为肿瘤生长抑制剂发挥作用。